As buying and selling week will come to near we review Sarepta Therapeutics Inc SRPT DMD gene treatment
submitted by marc88 63 days ago (via pointpleasantpark.capital)
As shares tumbled yesterday, we finish the trading 7 days by seeking at the Sarepta Therapeutics Inc. (SRPT) update on Duchenne muscular dystrophy study.
Add your comment
Please Login or Signup to leave a comment